Filtered By:
Management: National Institutes of Health (NIH)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 36 results found since Jan 2013.
Unpacking the Barriers to Medication Adherence May Move Us Closer to Eye Health Equity
In their article entitled “Racial and Ethnic Disparities in Cost-Related Barriers to Medication Adherence Among Patients With Glaucoma Enrolled in the National Institutes of Health All of Us Research Program,” Delavar et al analyzed responses regarding medication adherence in 3826 people with a diagnosis of glaucoma of t he 350 000 individuals who participated in the National Institutes of Health All of Us database. These responses were associated with self-reported demographic characteristics. Their essential findings were as follows: (1) individuals who self-reported African American race and Hispanic ethnicity wer...
Source: JAMA Ophthalmology - April 1, 2022 Category: Opthalmology Source Type: research
Scientists discover gene therapy provides neuroprotection to prevent glaucoma vision loss
An NIH-funded research project found that calcium modulator CaMKII protects the optic nerve in mice, opening the door to new sight-saving therapy.
Source: National Institutes of Health (NIH) News Releases - July 22, 2021 Category: American Health Source Type: news
Cataract surgery in infancy increases glaucoma risk
NIH-funded clinical trial shows risk is similar whether or not a cloudy lens is replaced with a lens implant. Study suggests lifelong monitoring is crucial to preventing glaucoma-related vision loss.
Source: National Institutes of Health (NIH) News Releases - December 17, 2020 Category: American Health Source Type: news
Understanding Eye ' s ' Plumbing ' Could Lead to Glaucoma Treatments
A University of Arizona Health Sciences study funded by a $2.3 million five-year grant from the National Institutes of Health National Eye Institute could help to develop future treatments for glaucoma and other diseases.
Source: The University of Arizona: Health - November 15, 2019 Category: Universities & Medical Training Authors: Jo Marie Barkley, UA College of Medicine – Tucson Source Type: research
Understanding the eye's 'plumbing' could lead to future treatments for glaucoma
(University of Arizona Health Sciences) A University of Arizona Health Sciences study funded by a $2.3 million five-year grant from the National Institutes of Health (NIH) National Eye Institute could help to develop future treatments for glaucoma and other diseases.
Source: EurekAlert! - Medicine and Health - November 14, 2019 Category: International Medicine & Public Health Source Type: news
Brain implant restores visual perception to the blind
Seven years ago, Jason Esterhuizen was in a horrific car crash that destroyed his eyes, plunging him into total darkness. Today, he ’s regained visual perception and more independence, thanks to an experimental device implanted in his brain by researchers at UCLA Health.“Now I can do things that I couldn’t do before,” said Esterhuizen, 30, who moved from his native South Africa to participate in the clinical trial at UCLA. “I can sort the laundry, find my way in lighted hallways without using a cane and cross the street more safely. It’s making my life mu ch easier.”The device is geared to people who used to...
Source: UCLA Newsroom: Health Sciences - September 18, 2019 Category: Universities & Medical Training Source Type: news
Are The Health Benefits Of Turmeric Too Good To Be True?
(CNN) — Alzheimer’s disease. Diabetes. Arthritis. Unwanted hair growth. Baldness. Infertility. Erectile dysfunction. Hangovers. Glaucoma. Cancer.
If you have an ailment, there’s a good chance that someone, somewhere, is studying whether turmeric can treat it. There are more than 15,000 manuscripts published about curcumin, the active ingredient in turmeric, and about 50 manuscripts added to this collection each week, according to the National Institutes of Health.
“It’s really taken on sort of panacea-like properties in terms of the things it’s being studied for and the things it has bee...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 7, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local TV turmeric Source Type: news
UH scientist working toward a glaucoma cure
(University of Houston) With $765,000 from the National Institutes of Health, University of Houston College of Optometry biomedical engineer Vijaykrishna Raghunathan is working towards a pharmaceutical cure for the irreversible disease Glaucoma.
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news
Butterfly wing inspires design of glaucoma sensor
Inspired by a clear butterfly wing, researchers designed a tiny implantable sensor to measure eye pressure. With further development, it could be tested in people.
Source: NIH Research Matters from the National Institutes of Health (NIH) - May 15, 2018 Category: Consumer Health News Source Type: news
UMKC lands $1.97M grant for glaucoma treatment
Researchers at the University of Missouri-Kansas City School of Medicine landed $1.937 million to develop a way to treat patients with end-stage glaucoma. The five-year grant from the National Institutes of Health will support principal investigator Karl Kador's research on ways to restore vision to patients with glaucoma and other eye disorders.
Kador, an assistant professor of ophthalmology and biomedical sciences, studies disease and injuries that lead to the death of retinal ganglion cells,…
Source: bizjournals.com Health Care:Physician Practices headlines - April 26, 2018 Category: American Health Authors: Elise Reuter Source Type: news
7 medtech stories we missed this week: March 24, 2017
[Image from unsplash.com]From companies receiving CE marking to other companies adjusting their distribution deals, here are 7 medtech stories we missed this week but thought were still worth mentioning.
1. Viveve Medical closes public offering
Viveve Medical announced that it closed its underwritten public offering of 8,625,00 shares of its common stock, according to a March 22 news release. The public offering price was $4 per share, and the company estimates that the net proceeds from the offering will be nearly $31.7 million after deducting underwriting discounts and commissions.
2. Masimo receives CE Mark for Rad-97 P...
Source: Mass Device - March 24, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Business/Financial News Clinical Trials Orthopedics Astute Medical Bonesupport Cerebral Therapeutics DiamiR Flowonix Glaukos Masimo Ortho Clinical Diagnostics Viveve Medical Source Type: news
Stem cell secretions may protect against glaucoma
NEI scientists find that stem cell exosomes promote survival of retinal ganglion cells in rats.
Source: National Institutes of Health (NIH) News Releases - January 27, 2017 Category: American Health Source Type: news
Leonard Cohen's Death Sheds Light On Link Between Falls And Health Problems
Legendary singer-songwriter Leonard Cohen died after falling in his home, his manager has now revealed, but can falls signal poor health in older adults?
Cohen’s death was first reported last week, but on Wednesday (Nov. 16), Cohen’s manager Robert Kory released a statement with more details, saying the songwriter fell in the middle of the night, and died in his sleep on Nov. 7. “The death was sudden, unexpected and peaceful,” Kory said.
It’s not clear if Cohen’s death at age 82 was related to his fall. But it’s known that several health conditions can affect a person’s risk ...
Source: Science - The Huffington Post - November 21, 2016 Category: Science Source Type: news
U.S.-India joint effort targets genes and traits to improve glaucoma screening, prevention, and treatment
Researchers from the U.S. and India have begun a new collaborative project to identify genetic risk factors and traits related to glaucoma, a leading cause of blindness worldwide. Funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), and India ’s Department of Biotechnology (DBT), the researchers’ goal is to help develop effective screening, prevention, and treatment strategies for glaucoma.
Source: News from NEI - October 4, 2016 Category: Opthalmology Authors: abiyub Source Type: news
